<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://www.law360.com/health/articles/213/federal-circuit-rules-for-merck-in-patent-dispute-with-teva?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T16:51:21Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/202/enzo-biochem-sues-affymetrix-for-breach-of-agreement?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T13:16:59Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/178/dutch-court-rules-against-micro-therapeutics-in-patent-dispute?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T07:17:09Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/174/impax-schering-plough-settles-claritin-d-24-hour-patent-suit-?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T07:17:08Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/170/uganda-to-buy-generic-anti-retrovirals?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T06:29:04Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/167/who-to-endorse-triple-dose-anti-hiv-generics?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T21:27:42Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/151/amersham-sues-perkinelmer-over-drug-technology-patents?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-11T05:48:08Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/165/clinton-foundation-brokers-deal-for-cheaper-hiv-generics?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T13:44:03Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/152/andrx-schering-settle-claritin-d-patent-dispute?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T04:12:19Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/148/conceptus-and-ovion-settle-patent-litigation-over-birth-control-system?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T09:16:41Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/125/takeda-sues-generic-makers-over-diabetes-drug-patents?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T19:02:03Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/117/bioprogress-starts-patent-action-against-stanelco?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T17:12:32Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/124/generic-drug-makers-sue-h-lundbeck-over-cipramil-patent?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T11:45:32Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/106/proposed-eu-ip-law-draws-mounting-criticism?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T16:51:19Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/90/in-setback-for-astrazeneca-e-u-court-rules-for-generics?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T13:35:28Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/86/unesco-adopts-declaration-on-human-genetic-data-?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T18:55:55Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/88/south-africa-glaxosmithkline-boehringer-ingelheim-abused-monopoly-?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-11T22:45:23Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/72/idec-obtains-summary-judgment-in-zevalin-suit?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T23:22:04Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/68/apec-readies-talks-on-common-patent-system?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T07:23:20Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/65/canada-union-proposes-measures-to-ban-evergreening-drug-patents?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T04:10:13Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/63/e-u-refusal-to-license-database-may-be-monopoly-abuse?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-11T10:38:02Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/71/novartis-sees-differentiated-process-for-biogenerics?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T19:48:33Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/51/fda-expected-to-allow-faster-approval-of-some-generics?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T17:40:52Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/57/chiron-roxane-settle-suit-over-tobramycin-patent?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T17:50:40Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/48/new-zealand-wraps-up-review-of-patent-law?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-11T05:46:06Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/46/lundbeck-settles-suit-vs-sandoz-over-citalopram?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T13:14:56Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/32/pfizer-urges-india-to-take-firm-stand-on-data-exclusivity-patents?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T11:55:31Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/30/appeals-court-upholds-ruling-favoring-transkaryotic-in-patent-suit?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T01:43:28Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/39/ontario-to-intervene-in-monsanto-patent-lawsuit?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T19:02:03Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/40/biotech-industry-complains-of-patent-bottleneck-in-taiwan?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T19:24:21Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/26/johnson-johnson-sues-barr-laboraties-over-contraceptive?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T16:18:08Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/12/court-rules-for-transonic-in-patent-dispute-with-hemametrics?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T05:11:10Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/20/biotech-experts-urge-taiwan-to-protect-drug-research-data?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T13:50:38Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/18/france-russia-sign-pact-on-technology-transfers?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T18:55:54Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/13/repligen-appeals-ruling-in-dispute-with-bristol-myers-?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T18:55:54Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/8/court-issues-summary-ruling-favoring-pfizer-in-patent-dispute?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T07:23:19Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/7/nutra-pharma-bio-therapeutics-settle-lawsuit?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T03:35:06Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/5/court-rules-for-napro-in-patent-dispute-over-cancer-drug?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T04:10:12Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
</urlset>
